BMY-14802 antagonizes harmaline- and D-serine-induced increases in mouse cerebellar cyclic GMP: Neurochemical evidence for a σ receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex in vivo

T. S. Rao, J. A. Cler, M. R. Emmett, S. Mick, S. Iyengar, P. L. Wood

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

BMY-14802 [α-(4-fluorophenyl)-4-(5-fluoro-pyramidinyl)-1-piperazine butanol], a potent σ ligand with poor affinity for dopamine and phencyclidine receptors in vitro, attenuated parenteral harmaline- and direct intracerebellar D-serine-induced increases in mouse cerebellar cGMP. Intracerebroventricularly injected BMY-14802 also antagonized the effects of intracerebellar D-serine, indicating a central mechanism. However, direct co-injection of BMY-14802 into the cerebellum failed to antagonize the D-serine-induced increases in cGMP, indicating a locus of action outside the cerebellum. In contrast, quisqualate-induced cGMP increases were not attenuated by BMY-14802. These results indicate a functional modulation of the N-methyl-D-aspartate/glycine/phencyclidine/ion channel complex-mediated events by BMY-14802, possibly through a transsynaptic mechanism, thus representing the first in vivo demonstration of a σ ligand modulation of a response mediated through the N-methyl-D-aspartate receptor complex.

Original languageEnglish (US)
Pages (from-to)978-982
Number of pages5
JournalMolecular pharmacology
Volume37
Issue number6
StatePublished - 1990
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'BMY-14802 antagonizes harmaline- and D-serine-induced increases in mouse cerebellar cyclic GMP: Neurochemical evidence for a σ receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex in vivo'. Together they form a unique fingerprint.

Cite this